These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8186135)

  • 1. Onychomycosis is more than a cosmetic problem.
    Scher RK
    Br J Dermatol; 1994 Apr; 130 Suppl 43():15. PubMed ID: 8186135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of onychomycosis on quality of life.
    Drake LA; Scher RK; Smith EB; Faich GA; Smith SL; Hong JJ; Stiller MJ
    J Am Acad Dermatol; 1998 May; 38(5 Pt 1):702-4. PubMed ID: 9591814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of toenail onychomycosis on patient quality of life.
    Elewski BE
    Int J Dermatol; 1997 Oct; 36(10):754-6. PubMed ID: 9372349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of quality of life in patients with toenail onychomycosis by Polish version of an international onychomycosis-specific questionnaire.
    Szepietowski JC; Reich A; Pacan P; Garlowska E; Baran E;
    J Eur Acad Dermatol Venereol; 2007 Apr; 21(4):491-6. PubMed ID: 17373976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Onychomycosis: A study of self-recognition by patients and quality of life.
    Bunyaratavej S; Pattanaprichakul P; Leeyaphan C; Chayangsu O; Bunyaratavej S; Kulthanan K
    Indian J Dermatol Venereol Leprol; 2015; 81(3):270-4. PubMed ID: 25851764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of onychomycosis on quality of life: development of an international onychomycosis-specific questionnaire to measure patient quality of life.
    Drake LA; Patrick DL; Fleckman P; Andr J; Baran R; Haneke E; Sapède C; Tosti A
    J Am Acad Dermatol; 1999 Aug; 41(2 Pt 1):189-96. PubMed ID: 10426887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validity of self-reported nail counts in patients with onychomycosis: A retrospective pilot analysis.
    Cham PM; Chen SC; Grill JP; Warshaw EM
    J Am Acad Dermatol; 2008 Jan; 58(1):136-41. PubMed ID: 17964690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coexistence of onychomycosis in psoriatic nails: a descriptive study.
    Natarajan V; Nath AK; Thappa DM; Singh R; Verma SK
    Indian J Dermatol Venereol Leprol; 2010; 76(6):723. PubMed ID: 21079333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Onychomycosis: burden of disease and the role of topical antifungal treatment.
    Daniel RC
    J Drugs Dermatol; 2013 Nov; 12(11):1263-6. PubMed ID: 24196334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality of life issues for patients with fungal nail infections.
    Drake L
    AIDS Patient Care; 1995 Dec; 9 Suppl 1():S15-7. PubMed ID: 11361427
    [No Abstract]   [Full Text] [Related]  

  • 11. Onychomycosis in primary school children: association with socioeconomic conditions.
    Gunduz T; Metin DY; Sacar T; Hilmioglu S; Baydur H; Inci R; Tümbay E
    Mycoses; 2006 Sep; 49(5):431-3. PubMed ID: 16922798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality of life in patients with toenail onychomycosis.
    Milobratović D; Janković S; Vukičević J; Marinković J; Janković J; Railić Z
    Mycoses; 2013 Sep; 56(5):543-51. PubMed ID: 23496237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NailQoL: a quality-of-life instrument for onychomycosis.
    Warshaw EM; Foster JK; Cham PM; Grill JP; Chen SC
    Int J Dermatol; 2007 Dec; 46(12):1279-86. PubMed ID: 18173524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality of life of persons with onychomycosis.
    Lubeck DP; Patrick DL; McNulty P; Fifer SK; Birnbaum J
    Qual Life Res; 1993 Oct; 2(5):341-8. PubMed ID: 8136799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multicentre, randomized, controlled study of the efficacy, safety and cost-effectiveness of a combination therapy with amorolfine nail lacquer and oral terbinafine compared with oral terbinafine alone for the treatment of onychomycosis with matrix involvement.
    Baran R; Sigurgeirsson B; de Berker D; Kaufmann R; Lecha M; Faergemann J; Kerrouche N; Sidou F
    Br J Dermatol; 2007 Jul; 157(1):149-57. PubMed ID: 17553051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What is the cost of onychomycosis?
    Sinclair R
    Australas J Dermatol; 1998 May; 39(2):131-2. PubMed ID: 9611389
    [No Abstract]   [Full Text] [Related]  

  • 17. Fungal Nail Infection.
    Muth CC
    JAMA; 2017 Feb; 317(5):546. PubMed ID: 28170480
    [No Abstract]   [Full Text] [Related]  

  • 18. Economic analysis of oral and topical therapies for onychomycosis of the toenails and fingernails.
    Casciano J; Amaya K; Doyle J; Arikian S; Shear N; Haspel M; Kahler K
    Manag Care; 2003 Mar; 12(3):47-54. PubMed ID: 12685377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health-related quality of life in patients with nail disorders.
    Reich A; Szepietowski JC
    Am J Clin Dermatol; 2011 Oct; 12(5):313-20. PubMed ID: 21834596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Onychomycosis with onychodystrophy or acrolentiginous melanoma with onychomycosis and onychodystrophy?].
    Blum A
    Hautarzt; 2012 Apr; 63(4):341-3. PubMed ID: 22527383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.